Login / Signup

Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.

Jun GongAlain C MitaZihan WeiHeather H ChengEdith P MitchellJohn J WrightSusan Percy IvyVictoria WangRobert C GrayLisa Meier McShaneLawrence V RubinsteinDavid R PattonP Mickey WilliamsStanley R HamiltonAjjai S AlvaJames V TricoliBarbara A ConleyCarlos L ArteagaLyndsay N HarrisPeter J O'DwyerAlice P ChenKeith T Flaherty
Published in: JCO precision oncology (2024)
inhibition.
Keyphrases
  • phase ii study
  • open label
  • phase iii
  • phase ii
  • locally advanced
  • study protocol
  • clinical trial
  • placebo controlled
  • randomized controlled trial
  • squamous cell carcinoma
  • rectal cancer
  • radiation therapy